Consulting
Discover unrealized connections and manage your product across the entire lifecycle, from research and development, compliance to launch and commercialization.
White Paper
Rare Diseases in APAC: The Unmet Potential
Part 1
Jul 24, 2024
Globally, the focus on rare diseases has grown considerably over the last few years. Even in the APAC region, rare disease area is gaining momentum owing to the pronounced disease burden and unique challenges that patients face. Countries in the region have varying degrees of maturity regarding rare disease management, with developed markets having more comprehensive ecosystems for care delivery and middle-income countries (e.g., India) still in the midst of establishing comprehensive policies, strengthening their regulatory frameworks to improve access to rare disease medications, and thus, on the cusp of unlocking significant potential.
In our two-part whitepaper series, we are discussing an overview of the rare disease landscape in the Asia-Pacific (APAC) region, covering the burden of disease, level of maturity, market size, challenges in rare disease management, and their potential solutions and innovations. Specifically, in this part 1 – Rare Diseases in APAC: The Unmet Potential, we examine the burden of rare disease in the APAC region, the level of maturity regarding rare disease care delivery in various APAC markets, and the potential size of these markets.
Stay tuned for part 2, where we will discuss Unlocking Solutions for Rare Diseases in APAC, covering current challenges in rare disease management, potential solutions, and innovations in the rare disease space.
Authors:
Puneet Singh
Consultant
Rijul Bhardwaj
Associate Principal
Devaraj Subramaniam
Associate Principal, Consulting Services